Close
VIRTUAL EVENT: World Thrombosis Day | Understanding why some people get blood clots
13 October 2022, 5:00 pm–6:00 pm
World Thrombosis Day aims to raise awareness of blood clots in veins and improve education. Join us for this fascinating lecture.
This event is free.
Event Information
Open to
- All
Availability
- Yes
Cost
- Free
Organiser
-
Kate Thomas & Dr Nephtali Marina-Gonzalez – Faculty of Medical Sciences
World Thrombosis Day is taking place on 13th October 2022. Its purpose is to raise awareness of blood clots in veins (venous thromboembolism). This is an important issue because venous thromboembolism is the leading cause of preventable death in hospitals in the UK. There are more than 32,000 cases of venous thromboembolism in hospitals in the UK each year with mortality of about 10%. In the United States venous thromboembolism results in more deaths than the combined total from AIDS, breast cancer and traffic accidents.
The first step in doing something about this is understanding the causes of this disease. Join us for this fascinating lecture to learn about blood clots and the strategies for prevention and treatment.
This lecture will be followed by a Q&A with our speaker, Dr Keith Gomez.
Follow the conversation on Twitter: #FMSLectures
About the Speaker
Keith Gomez
Consultant and Associate Professor in Haemostasis at UCL
Dr Keith Gomez trained at St Thomas' Hospital Medical School, University of London, and graduated in 1992. After studying haematology in the North London training programme he joined the Haemostasis Research Group at the Medical Research Council in London. The primary area of research for his doctoral thesis was the development of models of tissue factor-initiated coagulation.
After award of his PhD Dr Gomez took up his current post as Consultant and Associate Professor in Haemostasis in the Haemophilia Centre and Thrombosis Unit at the Royal Free Hospital in London. His main research interests include the genetic basis of inherited disorders of coagulation, the diagnosis and management of platelet disorders and the clinical management of the rarer factor deficiencies.